¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Tuberculosis of lung, bacteriologically and histologically negative"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maternity and infant hygiene
    ¸ð¼º¿µ¾ÆÀ§»ý
  • picture archiving and communicating system
    ¿µ»óÀúÀå¹×Àü¼Ûü°è
  • primary tuberculosis
    ¿ø¹ß°áÇÙ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • reactivation tuberculosis
    ÀçȰ¼ºÈ­°áÇÙ
  • renal tuberculosis
    ÄáÆÏ°áÇÙ, ½ÅÀå°áÇÙ
  • secondary tuberculosis
    ¼Ó¹ß°áÇÙ
  • salt-and-pepper fundus
    ÈÄÃ߼ұݸð¾ç¾ÈÀú, ÈÄÃ߼ұݸð¾ç´«¹Ù´Ú
  • wear and tear dermatitis
    ¹Ýº¹ÀÚ±ØÇǺο°
  • apex of lung
    ÇãÆÄ²À´ë±â, Æó²À´ë±â
  • artificial heart-lung apparatus
    Àΰø½ÉÀåÆóÀåÄ¡, Àΰø½ÉÀåÇãÆÄÀåÄ¡
  • air conditioner lung
    ¿¡¾îÄÁÆó, ¿¡¾îÄÁÇãÆÄ
  • bauxite lung
    º¸Å©»çÀÌÆ®Æó, º¸Å©»çÀÌÆ®ÇãÆÄ
  • cardiac lung
    ½É¼ºÆó, ¿ïÇ÷Æó, ½ÉÀåÅ¿ÇãÆÄ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maternal and child health
    ¸ðÀÚº¸°Ç
  • maternity and infant hygiene
    ¸ð¼º¿µ¾ÆÀ§»ý
  • intake and output record
    ¼·Ãë¹è¼³·®±â·Ï
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • law of weights and measures
    °è·®¹ý
  • trial-and-error learning
    ½ÃÇàÂø¿ÀÇнÀ
  • to and fro motion
    ¿Õº¹¿îµ¿
  • picture archiving and communicating system
    ¿µ»óÀúÀå¹×Àü¼Ûü°è
  • suck and snout reflex
    ÀԴٽñâ¹Ý»ç, »¡°íÇÓ±â¹Ý»ç
  • sip and puff switch
    È£Èí½ºÀ§Ä¡
  • to and fro absorbent system
    ¿Õº¹Èí¼ö½Äȸ·Î
  • to-and-fro sound
    ¸¶ÂûÀ½
  • apex of lung
    ÇãÆÄ²À´ë±â, Æó²À´ë±â
  • air-conditioner lung
    ¿¡¾îÄÜÇãÆÄ, ¿¡¾îÄÜÆó
  • artificial heart-lung apparatus
    Àΰø½ÉÀåÇãÆÄÀåÄ¡, Àΰø½ÉÀåÆóÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gastrointestinal tuberculosis
    À§Àå°ü°áÇÙ.
  • genital tuberculosis
    ¼º±â°áÇÙ.
  • hematogenous tuberculosis
    Ç÷Ç༺ °áÇÙ.
  • hilus lymph node tuberculosis
    Æó¹®¸²ÇÁÀý°áÇÙ(Áõ).
  • incipient tuberculosis
    Ãʱâ°áÇÙ.
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ)(¡­Ì¿ú· ñø), Ãʱâ°áÇÙ(Áõ).
  • pulmonary tuberculosis
    Æó°áÇÙ(øËÌ¿ú·).
  • pulmonary tuberculosis
    Æó°áÇÙ(øËÌ¿ú·)
  • reinfection tuberculosis
    Àç°¨¿°°áÇÙ(î¢ÊïæøÌ¿ú·).
  • reinfection tuberculosis
    Àç°¨¿°°áÇÙÁõ(î¢ÊïæøÌ¿ú·ñø).
  • Castanedas rat lung method
    Ä«½ºÅ¸³×´Ù ¼­Æó¹ý.
  • Coffee workers lung
    Ä¿Çǰø Æó
  • Heart-lung machines
    Àΰø½ÉÆó±â(ìÑÍïãýøËÐï)
  • Left lung, interior lobe
    ¿ÞÇãÆÄ, ¾Æ·¡¿±
  • TLC => total lung capacity
    ÀüÆó¿ë·®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • negative chronotropic
    ½É¹Ú¼ö°¨¼Ò¼ºÀÇ.
  • negative chronotropy
    ¹Ú(µ¿)¼ö°¨¼Ò(ÀÛ¿ë).
  • negative chronotropy
    ½É¹Úµ¿¼ö°¨¼ÒÀÛ¿ë.
  • negative contrast medium
    À½¼º Á¶¿µÁ¦
  • negative convergence
    À½¼º´«¸ðÀ½, À½¼ºÆøÁÖ(~ÜßñÍ).
  • negative declination
    ³»È¸¼±
  • negative dromotropy
    (½É)º¯Á¶°¨¼Ò(ÀÛ¿ë).
  • negative electricity
    À½Àü±â(ëäï³Ñ¨).
  • negative electrode
    À½±Ø(ëäп).
  • negative electron
    À½ÀüÀÚ
  • negative entropy
    À½¿£Æ®·ÎÇÇ.
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback inhibition
    À½¼ºµÇ¸ÔÀÓ¾ïÁ¦.
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü.
  • negative feeling
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
  • Mesenteries and peritoneal folds
    âÀÚ°£¸· ¹× º¹¸·ÁÖ¸§
    [¿¾ ¿ë¾î] Àå°£¸·
  • Coeloms and septa
    ü°­°ú Áß°Ý
    [¿¾ ¿ë¾î] ü°­°ú Áß°Ý
  • Gray matter (Nuclei and Columns)
    ȸ»öÁú(½Å°æÇÙ°ú ½Å°æ±âµÕ)
    [¿¾ ¿ë¾î] ȸ¹éÁú
  • Cartilages and Articulations of Larynx
    Èĵο¬°ñ ¹× ÈĵΰüÀý
    [¿¾ ¿ë¾î] Èĵο¬°ñ ¹× ÈĵΰüÀý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • negative superhelix
    À½(ëä) ¼öÆÛ³ª¼±
  • transport-negative mutant
    ¼ö¼Û°áÇÔ º¯ÀÌÁÖ(âÃáêÌÀùèܨì¶ñ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lung
    ÆóÀå
  • lung biopsy
    Æó»ý°Ë
  • lung field
    Æó¾ß
  • lung marking
    Æó¹«´Ì
  • lung marking
    ÆóÀ½¿µ
  • middle lung field
    Á߯ó¾ß
  • open lung biopsy
    °³Èä»ý°Ë
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ
  • restrictive lung disease
    ±¸¼Ó¼ºÆóÁúȯ
  • upper lung field
    »óÆó±¸¿ª, »óÆó¾ß
  • wet lung
    ºÎÁ¾Æó, ½ÀÀ±Æó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TB-RD tuberculosis and respiratory disease
AFB Acid-Fast Bacillus(Type that causes Tuberculosis)
NTA   1) Naso-Tracheal Aspiration
  2) National Tuberculosis Association
NTM Non-Tuberculosis Mycobacteria
TB, Tb TuBerculosis; °áÇÙ
  = Tbc
  ? CIX of Op
    1. Pulm...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MOTT Mycobacteria Other Than Tuberculosis
MT Mycobacterium Tuberculosis
MTD Mycobacterium Tuberculosis Direct Test
M-TB Mycobacterium tuberculosis
MtbC Mycobacterium tuberculosis Complex
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endogenous tuberculosis
    ³»Àμº °áÇÙ
  • endotracheal tuberculosis
    ±â°ü³» °áÇÙ
  • exudative tuberculosis
    »ïÃ⼺ °áÇÙ
  • hematogenous tuberculosis
    Ç÷Ç༺ °áÇÙ
  • kidney tuberculosis
    ½Å °áÇÙ
  • mucosal tuberculosis
    Á¡¸· °áÇÙ
  • open tuberculosis
    °³¹æ °áÇÙ
  • pharyngeal tuberculosis
    ÀεΠ°áÇÙ
  • pulmonary tuberculosis
    Æó °áÇÙ
  • renal tuberculosis
    ½Å °áÇÙ
  • secondary tuberculosis
    ÀÌÂ÷¼º °áÇÙ
  • tuberculosis cutis colliquativa
    À¶ºØ¼º ÇǺΠ°áÇÙ
  • tuberculosis cutis luposa
    À¶ºØ¼º ÇǺΠ³¶Ã¢
  • tuberculosis cutis verrucosa
    ¿ì»ó ÇǺΠ°áÇÙ
  • tuberculosis miliaris
    ¼Ó¸³ °áÇÙÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
negative, false A result that appears negative but fails to reveal a situation. An example of a false negative: a particular test designed to detect cancer of the toenail is negative but the person has toenail cancer.
(12 Dec 1998)
negative feedback This occurs where the products of a process can act at an earlier stage in the process to inhibit their own formation. The term was first used widely in conjunction with electrical amplifiers where negative feedback was applied to limit distortion of the signal by the amplification mechanism. Tends to stabilise the process. In contrast to positive feedback.
(18 Nov 1997)
negative focal length <physics> The focal length of a negative lens. Parallel rays impinging on a negative lens can be traced to a virtual focus which exists on the same side of the lens as the impinging rays. The distance from the second principal point of the lens to this second focal point is measured on the same side of the lens as is the object.
See: negative lens, focal length.
(05 Aug 1998)
negative G Gravity in a foot-to-head direction in flying, or in standing on one's head; opposite of positive G.
(05 Mar 2000)
negative image Continuation of visual impression after cessation of stimuli causing the original image.
(12 Dec 1998)
negative lens <physics> A lens with a negative focal length. The edge of a negative lens is thicker than the centre. The three negative lenses are, according to their figure: planoconcave, double concave or biconcave, and diverging concavoconvex or diverging meniscus.
See: lens, simple.
(05 Aug 1998)
negative meniscus A convexoconcave lens in which the power of the concavity exceeds that of the convexity.
Synonym: negative meniscus.
(05 Mar 2000)
negative phase The period during which the opsonic index is lowered following the injection of a vaccine.
(05 Mar 2000)
negative pressure Pressure less than that of the ambient atmosphere.
(05 Mar 2000)
negative regulation Negative feedback in biological systems mediated by allosteric regulatory enzymes.
(18 Nov 1997)
negative S Characteristic sedimentation behaviour of a lipoprotein fraction of plasma in a centrifugal field in a medium of appropriate density, achieved by adding a salt or D2O to the plasma.
Synonym: negative S, Svedberg of flotation.
(05 Mar 2000)
negative scotoma A scotoma that is not ordinarily perceived, but is detected only on examination of the visual field.
(05 Mar 2000)
negative stain <technique> Stain forming an opaque or coloured background against which the object to be demonstrated appears as a translucent or colourless area; in electron microscopy, an electron opaque material, such as phosphotungstic acid or sodium phosphotungstate, is used to give detail as to surface structure.
(05 Mar 2000)
negative staining Microscopic technique in which the object stands out against a dark background of stain. For electron microscopy the sample is suspended in a solution of an electron dense stain such as sodium phosphotungstate and then sprayed onto a support grid. The stain dries as structureless solid and fills all crevices in the sample. When examined in the electron microscope the sample appears as a light object against a dark background. Quite fine structural detail can be observed using negative staining and it has been used extensively to study the structure of viruses and other particulate samples.
(18 Nov 1997)
negative stranded RNA virus <virology> Class V viruses that have an RNA genome that is complementary to the mRNA, the positive strand. They also carry the virus specific RNA polymerase necessary for the synthesis of the mRNA. Includes (Rhabdoviridae, Paramyxoviridae and Myoviridae (for example the T even phages).
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • again and again
    ¹Ýº¹Çؼ­
  • and
    ±×¸®°í
  • and not ~ either
    ¶Ç ~ ¾Æ´Ï´Ù(=nor)
  • and so forth
    ±âŸ µîµî
  • and so on
    ..µîµî
  • and such
    µûÀ§,µîµî
  • and that
    ±×°Íµµ,°Ô´Ù°¡
  • both ~ and -
    ~ µµ - µµ (µÑ´Ù)
  • by and by
    ÀÌÀ¹°í
  • by-and-by
    ¹Ì·¡
  • checks and balances
    °ßÁ¦¿Í ±ÕÇü
  • every now and then
    À̵û±Ý
  • here and there
    ¿©±âÀú±â¿¡
  • hide-and-go-seek
    ¼û¹Ù²ÀÁú
  • hide-and-seek
    ¼û¹Ù²ÀÁú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á